- Previous Close
1,055.70 - Open
1,051.05 - Bid 1,095.75 x --
- Ask 1,095.80 x --
- Day's Range
1,050.00 - 1,098.00 - 52 Week Range
693.20 - 1,248.00 - Volume
3,920 - Avg. Volume
10,638 - Market Cap (intraday)
26.92B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
30.77 - EPS (TTM)
35.43 - Earnings Date Jan 23, 2025 - Jan 27, 2025
- Forward Dividend & Yield 25.00 (2.29%)
- Ex-Dividend Date Jul 23, 2024
- 1y Target Est
--
Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.
www.novartis.in62
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: NOVARTIND.BO
View MorePerformance Overview: NOVARTIND.BO
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOVARTIND.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOVARTIND.BO
View MoreValuation Measures
Market Cap
26.92B
Enterprise Value
21.00B
Trailing P/E
30.81
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.83
Price/Book (mrq)
3.69
Enterprise Value/Revenue
6.10
Enterprise Value/EBITDA
16.67
Financial Highlights
Profitability and Income Statement
Profit Margin
25.33%
Return on Assets (ttm)
5.47%
Return on Equity (ttm)
12.21%
Revenue (ttm)
3.45B
Net Income Avi to Common (ttm)
874M
Diluted EPS (ttm)
35.43
Balance Sheet and Cash Flow
Total Cash (mrq)
5.97B
Total Debt/Equity (mrq)
0.83%
Levered Free Cash Flow (ttm)
591.83M